Back
75· Active
Health & Science1d 22h ago
The FDA has granted expanded approval for Eli Lilly’s weight-loss drug Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA) and Eli Lilly
What
The FDA has granted expanded approval for Eli Lilly’s weight-loss drug Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.
When
Sun, 07 Jun 2026 11:50:06 GMT · 1d 22h ago
Where
Silver Spring, Maryland, USA · 39.0351°N, 77.0146°W
Why
Clinical trial data demonstrated that the GLP-1 medication significantly reduced the number of breathing interruptions during sleep by up to 63%.
The Frontline Impact
How this affects you
Patients with both obesity and sleep apnea now have a non-device alternative to CPAP machines, potentially improving sleep quality and cardiovascular outcomes for millions.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.